HapMap samples using full filtering of human reads (see Method section and Table 1 for similarity measures). Thermoanaerobacter wiegelii (ERR055396) from HapMap sample ERR055396. Coverage is restricted to few narrow regions of the genome whereas the majority of the genome is not represented in the sequenced sample. Thermoanaerobacter wiegelii has limited sequence similarity to other bacterial organism and the two covered regions represent only a fraction of the unique genome. (C) Genomic sequencing coverage of Propionibacterium acnes from HapMap sample DRR000615 is more uniform throughout the genome and therefore more likely to be a correct identification. Staphylococcus aureus (SRS065347) Bacteroides vulgatus (SRS065347) "hg19" columns represent the initial microbiome detection in four gastric biopsy samples by MetaPhlAn and Kraken after removing reads mapped to hg19. "filtered" are the identification results after more extensive filtering of human reads using additional human assemblies and repeat regions. Most top-ranked species were subsequently determined to be incorrectly identified and were removed by either filtering human DNA steps or genome coverage evaluation steps. 
Comparison of Microbiome Detection Methods
Detection of microbiome composition from gastric biopsies is confounded by the high abundance of host human DNA that can lead to misidentification of bacteria species due to similarities between human and bacterial segments as well as incomplete coverage of bacteria genome. We modified the PathSeq pipeline [1] , which includes extensive human DNA filtering steps, with additional genomic coverage evaluation step to obtain accurate microbial identification from sample with low abundance of bacteria. These steps are particularly important in cases where host DNA is the most abundant species in the samples in contrast to other samples where bacterial DNA is predominant. In order to comprehensively evaluate the performance of our pipeline and illustrate the importance of these additional filtering steps in samples where bacterial cells are underrepresented relative to host cells, we compared our pipeline with two other widely used methods -MetaPhlAn [2] and Kraken [3] -using samples from gastric biopsies, the HapMap project [4] , The Human Micriobiome Project (HMP) [5] , The Cancer Genome Atlas (TCGA), a non-malaria febrile illness study, and a Cystic Fibrosis study. All samples were aligned to the hg19 human reference genome with BWA (version 0.6.2), and the remaining unmapped reads were analyzed by our pipeline, MetaPhlAn (version 1.7.1, using default parameters and bowtie2db), and Kraken (version 0.10.5-beta, default parameters using MiniKraken DB).
Overall there is good concordance between the bacteria levels detected by our approach and those detected by MetPhlAn and Kraken as measured by cosine similarity ( Table 1 ). The main differences are attributed to detection of low levels bacteria by MetaPhlAn and Kraken and the misidentification of remaining human reads. • Initail analysis on gastric biopsy samples
We initially applied MetaPhlan to 15 biopsy samples and the top 12 most abundant bacteria are listed in Supplementary Figure 1 . Four species were determined to be incorrectly identified by genomic coverage evaluation (Candidatus Carsonella ruddii, Candidatus Sulcia muelleri, Candidatus Zinderia and Wigglesworthia glossinidia) and six additional species (Borrelia afzelii, Borrelia garinii, Borrelia recurrentis, Borrelia spielmanii, Buchnera aphidicola and Fusobacterium periodonticum) had insufficient coverage for positive identification.
Four of the samples (05-Antrum-B2, 07-Antrum-B2, 08-Antrum-B2 and 10-Antrum-B1) were evaluated by Kraken (Supplementary Figure 8) with similar results as MetaPhlan. All 13 top-ranked species were identified in all four samples and with the exception of Helicobater pylori, they were in similar abundance levels in all samples. With the exception of H. pylori levels, that were confirmed by clinical tests, there was little support for the presence of other bacteria in human samples by literature search or by careful examination of data.
• Evaluation of additional human DNA filtering steps on microbiome detection
We speculated that many of the false bacteria identification are derived from human DNA with partial similarity to bacteria genomes. We therefore performed a more stringent filtering of human reads including mapping to additional assembled human genomes, all human reads in GenBank and repeat regions as outlined in the Method section. We then reevaluated MetaPhlan and Kraken against our approach using four gastric samples (Supplementary Figure 8) .
Overall, the number of reads mapping to the false identification falls off dramatically with successive filtering (Figure 2A,C) , and the cosine similarity of each sample between our pipeline and other methods increased (Supplementary Table 1 ). However, a number of questionable identification are still reported by both MetaPhlan and Kraken due to low number of mapped reads or genomic coverage at few localized positions. Many of these can be excluded by simple coverage and uniformity filters. In addition, Kraken identification is based on k-mer matches to the target genome, which is sensitive to choice of k-mer length. For example, close inspection of 3 species (Alteromonas macleodii, Prevotella melaninogenica, and Pseudomonas stutzeri) identified by Kraken alone found that all of the reads had less than 70% similarity to their target genome (by BLAST and MEGABLAST searches) indicating that the parameters of k-mer matches may need to be modified for this specific identification task.
• Comparisons using HapMap samples
HapMap [4] samples were used as negative control samples to evaluate the effect of human DNA on microbial identification. Candidatus Carsonella ruddii and Candidatus Sulcia muelleri were detected by both MetaPhlAn and Kraken as noted in the results section dor. Besides them, each method identified a unique set of bacteria. Careful examination of the genomic coverage of these species indicated non-uniform coverage suggesting that these bacteria are not likely to be present in the sample.
MetPhlan identified: Borrelia afzelii, Borrelia garinii, Borrelia recurrentis, Borrelia spielmanii, Buchnera aphidicola, Candidatus Zinderia, Fusobacterium nucleatum, Fusobacterium periodonticum, Wigglesworthia glossinidia (Supplementary Figure 2) .
Similarly Kraken uniquely identified: Achromobacter xylosoxidans, Alteromonas macleodii, Anaplasma centrale, Caldanaerobacter subterraneus, Escherichia coli, Flavobacterium psychrophilum, Mycoplasma hyopneumoniae, Mycoplasma hyorhinis, Thermoanaerobacter wiegelii (Supplementary Figure 2 ).
Many of the bacteria species identified in the HapMap samples were identified in similar levels in the gastric samples suggesting that residual human reads may account for these identifications.
• Comparisons among three methods on HMP samples
In order to evaluate the identification performance of our pipeline on normal metagenomics samples we randomly selected three posterior fornix samples from the HMP [5] as positive control samples. The identifications of our pipeline showed the very high cosine similarities to two other methods ( Table 1 ).
The majority of the discrepancy between our bacterial identification and those identified by MetaPhlAn and Kraken can be attributed to low read coverage or localized genomics coverage that were filtered out by our approach. There are two species that were were not identified by our approach ( Figure 5 ). Bifidobacterium unclassified was identified by MetaPhlAn only in sample SRS024428 due to a genus-level marker that is present in MetaPhlAn database. Achromobacter xylosoxidans was identified in all three samples by Kraken and all of the reads mapped to Achromobacter xylosoxidans had less than 70% similarity to its genome (by BLAST and MEGABLAST searches) suggesting that it is a misidentification.
• Comparisons using sputa samples from Cystic Fibrosis patients
Two sputa samples from a published Cystic Fibrosis study were used as the extra positive controls for evaluation. These two samples contain around 18% reads which cannot be mapped to hg19 reference genome. Although the relative abundance of microbial contents is lower than HMP samples, it is much higher than biopsy samples. The microbiome profile similarities detected by the three methods were highly consistent with each other, similarly to the HMP samples ( Table  1 ).
The majority of the differences between our pipeline and the two other methods were also limited to the low content species. Most of species not in our results didn't pass the genomic coverage criteria, such as, Candidatus Zinderia, Neisseria mucosa, Neisseria meningitidis, Streptococcus infantis, Streptococcus vestibularis, and Veillonella atypical from MetaPhlAn's results, Alteromonas macleodii, Mycoplasma hyopneumoniae, and Mycoplasma hyorhinis from Kraken's results. Achromobacter xylosoxidans from Kraken was identified as a false positive with the same reason in HMP samples. We missed three species Gemella haemolysans, Granulicatella elegans, and Neisseria cinerea detected by MetaPhlAn, since they are not included in our bacteria genome database.
• Comparisons using other human DNA enriched samples
In order to estimate the applicability of microbial identification on other human DNA enriched samples which are similar to our gastric biopsy samples, we chose five tumor samples with high bacterial content from different TCGA studies. The results ( Figure 6 ) revealed that most species with high abundance could be detected by all three methods. Some bacteria were missed by MetaPhlAn and Kraken, despite their uniform genomic coverage, that were previously reported as pathogen or commensal bacteria by previous studies. For example, Kraken did not identify Bacteroides sp. from TCGA-CM-4750-01A, and MetaPhlAn missed Parabacteroides distasonis (TCGA-AG-A008-01A) which is one of most common species isolated from human feces [6] .
Although there is good agreement of the dominant species identified by all three methods, the cosine similarity between our pipeline and two other methods are very poor in several samples (Ta-ble 1). This can be attributed to consistent misidentification by both MetaPhlAn and Kraken of few specific species. Kraken reported high abundance of Achromobacter xylosoxidans in many samples, and MetaPhlAn consistently identified Candidatus Carsonella ruddii, Candidatus Sulcia muelleri, and Candidatus Zinderia. These species were repeatedly detected by MetaPhlAn and Kreken in almost all samples evaluated in this study. However, their reported proportions in the low bacterial content samples are significantly higher than in other sample types.
Both MetaPhlAn and Kraken are optimized for fast identification of microbial species from microbialenriched samples. MetaPhlAn maps sequenced reads to species specific genomic regions that have no similarity to other bacteria or human DNA. Kraken identifies bacteria by matching k-mers from sequenced reads to database of k-mer derived from bacterial genomes and assigning the reads to the lowest common ancestor. Both methods are significantly faster than our identification pipeline and preform well on HMP samples. However, in samples where bacteria is in low abundance sequence similarity among human and bacteria DNA, as well as low coverage of bacteria, can significantly impact species identification. The results from analysis of our biopsy samples as well as from HapMap, HMP, TCGA samples, and additional gastric biopsy samples illustrate that regardless of the species identification approach careful filtering of human reads and evaluation of genomic coverage are required for accurate identification of bacteria in samples with low bacteria levels.
